chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a female patient who on 09-JUN-2010, was vaccinated with a dose of ZOSTAVAX (Merck). Subsequently the patient experienced "her arm somewhat soar", and had a bright red mark the size of a golf ball on the injection site and it was hard. At the time of reporting, the adverse events persisted. It is unknown if the patient sought medical attention. No further information is available.
Patient stated that she had nerve pain radiating up her head and neck after she received the shot. Note the injection was given high on her shoulder.
Information was received on 21-MAR-2017 from a lawyer regarding a case in litigation. It is alleged in litigation that a female patient of unknown age in 29-AUG-2013, was inoculated with ZOSTAVAX (dose, route of administration, site of administration, lot number, expiration date were not reported) for the prevention of shingles. The vaccine was administered by an unspecified health care worker at the patient's pharmacy. Prior to receiving ZOSTAVAX vaccine, the patient has never suffered from or been diagnosed with herpes zoster, or any other ailment collectively referred to as "shingles". On or about 11-NOV-2015, the patient presented to her medical center with symptoms of a persistent, painful rash on her abdominal region. The patient was diagnosed by her physician with herpes zoster, the virus also known as shingles. As a direct result of the vaccine, the patient suffered, is suffering and/or will continue to suffer from mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, she suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient has incurred and will continue to incur medical expenses and other economic harm as a direct result of the use of ZOSTAVAX. The events of shingles on the herpes zoster and emotional distress were considered disabling. Additional information has been requested.
Had the shot 10 am. At 7 pm felt fatigued , a bit of an upset stomach. The following day was tired, had a headache (I very rarely have a headache!) and around 5 pm had severe chills , my chin couldn?t stop shaking. And muscle aches . Then bad diahreah came on quickly and continued from 9 pm to 4:00 am at which time is got very dizzy , then blacked out and woke up with my face on the carpet. Then projectile vomited five times while I was calling 911 as I was alone at the house and didn?t want to pass out again. Taken by ambulance to emergency room. Temp was 100.1. Given 2 x 1000  cc water intervenously. Was released at 8 am - still very nauseated , but better , took one zophran through out that day. Continued to be severely fatigued but no fever . Was in bed for the following three days due to fatigue.  I write down everything I eat so reviewed and all was normal stuff that my husband had also eaten and I hadn?t gone out to eat for several days prior. I had a reaction to the first shingles shot though not as severe. Was fatigued for two days and upset stomach with first shot. Never had reactions to any other shots .
81-year-old female presents emergency department by private automobile no acute distress.  Vital signs are stable.  5-hour ago she had a bowel movement and there was blood in her stool.  Initially her granddaughter stated it was bright red within a centimeter been dark red.  She does not have a history of diverticulosis or rectal bleeding or hemorrhoids.  No blood thinners.  No abdominal pain or diarrhea.  She was released from Bay med last week for pneumonia and UTI.  She is done with her antibiotics.
11/21/10 2:20 PM Large erythematous, warm, indurated area surrounding where 2 immunizations given 11/19/10. Pt was seen in ED and given 1 dose of KEFLEX. Cephalexin 250 mg/5 ml, 7 1/2 ml every 12 hrs x 5 days ordered 11/21/10.
Information has been received from a physician concerning a 10 year old male who on 31-JUL-2000 was vaccinated with a first dose of MMR. On 03-DEC-2009 the patient was vaccinated with a third dose of MMR (lot # 664363/0554Y). On 25-DEC-2009 the patient experienced mumps (thought the date diagnosed was reported as 30-NOV-2009). Other symptoms presented by the patient included pain under both ears. On 04-DEC-2009 the patient had blood work done (results not reported). The patient was afebrile. The patient's outcome was unknown. Follow-up information was received from the physician reporting that the patient experienced mumps on 11-NOV-2009 (previously reported as 25-DEC-2009) and was diagnosed on 15-NOV-2009 (previously reported as 30-NOV-2009). The patient developed right parotitis and was afebrile. No further information is available.
bilateral pleural effusions; This is a spontaneous report from a contactable consumer (patient). This is the first of two reports. This report concerns events occurred after the first dose of BNT162B2. A 75-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283), administered in the right arm on 12Jan2021  at dose 1, single for COVID-19 immunisation, at the age of 75-years-old. Medical history and concomitant medications were reported as none. Family medical history relevant to the adverse events was none. The patient previously received shingles vaccine and flu vaccine for immunisation and he did fine, no adverse events occurred. Additional vaccines administered on same date of BNT162b2 and prior vaccinations (within 4 weeks) were none. Patient wanted to report some side effects that he did not know if they were from the vaccine, but they seemed to be. He stated that company would get the 3rd shot in the near future, and if he got the same symptoms again, he wanted it to be on the record. Patient had his first shot on 12Jan2021, and on 22Jan2021, after taking the shot, for several days or a week or so he had trouble breathing or getting enough oxygen. It took a while for the fluid to build up; probably 3-4 days later, he was having trouble walking back and forth in house with his breathing. He went to the emergency room (ER), and he was diagnosed with bilateral pleural effusions, which was something he had never had before. They drained a liter and a half of fluid out of his chest cavity. Patient was treated in the ER and released. Treatments included draining fluid, several CT scans, x-rays, and tests of all different kinds in 2021, the whole procedure took about 6 months. They did a lot of examining trying to figure out what it was, but they never figured it out. Patient stated being it was after his first dose and again after the second dose, they figured it was the vaccine. Patient stated that if there was a booster shot and he got the same problem he would be 99% sure that the vaccine was what caused the pleural effusions and fluid. The adverse events required a visit to the ER, no admission to hospital. They wanted him to stay overnight but they figured it would be best not to; the events also required a physician office visit. The outcome of the events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101000025 same patient/SD, different AE/dose
1st COVID Vaccine 2/13/2021- Fatigue only 2nd COVID Vaccine 3/13/2021- High fever and severe back pain for 3 hours.
some patients who received Moderna vaccine post the expiration date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (some patients who received Moderna vaccine post the expiration date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (some patients who received Moderna vaccine post the expiration date). In November 2021, EXPIRED PRODUCT ADMINISTERED (some patients who received Moderna vaccine post the expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.  Reporter stated that the vaccine was pulled from the freezer on 15-Nov-2021 and moved to the refrigerator and administered on 15-Nov-2021 and 16-Nov-2021.  Company Comment : This case concerns a patient, unknown age and gender, with no known medical history, who experienced the non-serious event of expired product administered. The event occurred  on the same day after unspecified dose of mRNA 1273 vaccine. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report; Sender's Comments: This case concerns a patient, unknown age and gender, with no known medical history, who experienced the non-serious event of expired product administered. The event occurred  on the same day after unspecified dose of mRNA 1273 vaccine. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report
Severe muscle soreness in right arm, muscle aches, fatigue, arthritis pain, fever, diarrhea and nausea for three (3)  days. This has been self reported on the third day after the vaccines, therefore it is unknown when side effects will resolve.
This spontaneous report was received from a Registered Nurse and refers to a unknown patients of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On unknown dates, the patients were vaccinated with improperly stored unspecified doses of RECOMBIVAX HB  for prophylaxis (lot number M039201, with an expiration date of 04-NOV-2018 and lot number L016959, with an expiration date of  12-MAR-2018) (strength, dose and frequency were not reported). No concomitant medications were provided. The doses of the vaccine experienced a temperature excursion from 32 degrees Fahrenheit (F) to 35 degrees F for 228 hours and from 47 degrees F to 77 degrees F for 18 hours and 20 minutes. The aforementioned temperature was identified due to a data logger. There were no previous temperature excursions reported. This is one of several reports received from the same reporter. Additional information has been requested. ; Sender's Comments: US-009507513-1704USA003224: US-009507513-1704USA003228: US-009507513-1704USA003014: US-009507513-1704USA003227: US-009507513-1704USA003223: US-009507513-1704USA003225:
Shots administered at 11:30 on 7/30/15. Mom noticed a large red hive around injection area immediately after. Hives continued to spread throughout entire body, worst on trunk.
so I have to start taking a beetroot supplement (treatment) to get the blood flow back to normal; I noticed a reaction; I felt the tingling again; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "brain cancer" (unspecified if ongoing), notes: brain cancer survivor (history); "mild neuropathy" (unspecified if ongoing), notes: it 'affect' that in my hand and feet with neuropathy; "chemotherapy", start date: 2008, stop date: 2008, notes: had 'forms' the chemotherapy in 2008 along with the radiations to my brain; "radiations", start date: 2008, stop date: 2008, notes: had 'forms' the chemotherapy in 2008 along with the radiations to my brain. The patient's concomitant medications were not reported. The following information was reported: CARDIOVASCULAR DISORDER (non-serious), outcome "recovered", described as "so I have to start taking a beetroot supplement (treatment) to get the blood flow back to normal"; PARAESTHESIA (non-serious), outcome "unknown", described as "I noticed a reaction; I felt the tingling again". Therapeutic measures were taken as a result of cardiovascular disorder, paraesthesia.  Additional information: It was reported that the patient had chemotherapy and radiations to brain and it affected in the hand and feet with neuropathy, and it was been there since, it repaired some but still the hands and feet remained cold because the blood flow in the extremities was rather weak. The patient hesitated about getting the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
no adverse reaction to vaccine occurred at time of administration or after administration. 0845 on 9/27/2023 minor patient was scheduled to receive Bexsero. Nurse pulled and administered Engerix-B peds to pt (R) deltoid. Upon completion, error was noted to both pt and father. The use of Engerix B peds was then explained to both pt and father. No adverse reaction noted. Bexsero IM to (R) deltoid administered.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Urinated on herself-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Shakiness-Medium, Additional Details: Immediately after vaccination she started to feel "awful" and unable to describe exactly what was wrong. She was lightheaded, shaky and dizzy. She lost consciousness for about 1-2 minutes and paramedics were called. Once consciousness was regained, she lied down and started to feel better. She continued to lie down until paramedics showed up and assessed her. She was feeling better and was not taken to the hospital.
Immediately after shot a bruise appeared - it has faded away but now I have a red circle in the same area. A lympnode in my left armpit seems to be swollen and painful - this began on Monday 2/15/21
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: After receiving Moderna and high dose flushot on 10/24/22, 2 days later, she had symptoms of rash, swelling lips, tongue, and itchy eyes. She reported to Urgent  care and received Prednisone to help with symptoms. According to her, she believes it was due to vaccines.
Adverse effect of other vaccines and biological substances, initial encounter on 2021-12-08.
States within 1-2 hrs (L) arm painful, tingling, hand discolored, (L) side body felt weak over course of few days until seen, symptoms improved but not resolved
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2015, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 16-DEC-2015, the patient was treated by a physician for a blistering vesicular outbreak that was diagnosed as severe herpes zoster. The patient was prescribed gabapentin and lidocaine for management of painful symptoms and chronic pain. The outcome of the events is unknown. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Approx 5 min after imm were administered client reports feeling "light headed", color pale. Had syncope episode on way to assisting client to lying position. Noted slight twitching or mild jerking as client became unresponsive for approx 10 seconds. Legs elavated. Color returned. BP 120/80. left in supine position for approx 15 min. Assisted to sitting position, BP remined 120/80. Ambulated out of facility per self accompanied by Mom.
Td was given in left forearm as a intradermal (ID) vaccine like Tb instead of intramuscular (IM).
Soon after the booster I started getting shortness of breath and dry cough. Was getting worse so started getting tests and found out I had Pulmonary Fibrosis and Sjögren?s autoimmune. Was told it could be from the booster or Covid. And could if brought my autoimmune disease out as well. Though I had completely recovered from Covid. It wasn?t until after the booster I started having issues.  Before I was a fitness trainer. Ran 3 miles a day/walk 2. Martial artist.  Then all of a sudden I couldn?t make the bed without getting out of breath.  Now on CellCept. Was on prednisone for 2 months.  CellCept helping manage things though I?m told they?re not curable. :( And my husband gets disability and insurance won?t help me with my medical bills because of his income. We?re paying around $300+ for me and his son with help.  Now told we don?t qualify because income isn?t enough and we?ll owe $3000-$4000 for last few months they did help. Our premium will go up to $1400 a month. And I have $6000 + in medical bills the insurance doesn?t cover. If I don?t get healthcare my prognosis is very bad. So that?s where I am now. :(( but from what I?ve seen in many Covid groups is a lot have all of a sudden gotten pulmonary fibrosis and autoimmune like me after their boosters. So my autoimmune doctor recommended I report it.
Erythema at injection site.  Also infected site.  Pt was prescribed Keflex x 1 week.  Left cervical lymph node swollen.  Pain at injection site.
Patient had seizure and was unresponsive for a few seconds. Family went to the emergency department and patient had fever documented but no previous sick symptoms. WBC showed elevated bands but no significant other ABN.
About 2 weeks after Shingles shot, I contracted chicken pox-like marks.  Mild.  Only about 5 pox.  I know what they look like.  It wasn't anything else.  They all weeped for a time and then crusted over.  My Dr. and the Pharmacist seemed uninterested even though I couldn't find anything on the internet similar to my symptoms.  My wife's reaction was much more serious.  She was very sick for more than three weeks with aches, chills, fever and severe respiratory distress which all started within a few hours of receiving the shot. No pick marks.
Intussusception. 8/24/09 Hospital records received DOS 7/21/09 to 7/24/09 Assessment: Dehydration, viral gastroenteritis. Ileocolic intussusception. Patient presented with intemittent episodes of fussiness and irritability, one bowel movement per day (often large), lethargy, change in normal behavior, decreased oral intake, decreased urine output, episode of bloody emesis, bloody bowel movement. Oral thrush.
I have flu like symptoms; Severe headache; Have not been able to get out of bed; Body ache; Chills; I never get sick and I can't afford to get sick; Fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 10Sep2021 (Lot number: FC3183) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 11Sep2021, outcome "unknown", described as "I have flu like symptoms"; HEADACHE (non-serious) with onset 11Sep2021, outcome "unknown", described as "Severe headache"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 11Sep2021, outcome "unknown", described as "Have not been able to get out of bed"; PAIN (non-serious) with onset 11Sep2021, outcome "unknown", described as "Body ache"; CHILLS (non-serious) with onset 11Sep2021, outcome "unknown", described as "Chills"; ILLNESS (non-serious) with onset 11Sep2021, outcome "unknown", described as "I never get sick and I can't afford to get sick"; PYREXIA (non-serious) with onset 11Sep2021, outcome "unknown", described as "Fever". The Consumer stated that I just had a quick question. I have a question in regard to how long the symptoms after the 1st dose last consumer stated the first one, I got the 1st one yesterday and it has been 24 hours and I have flu like symptoms, severe headache, have not been able to get out of bed and chills and body aches. Now, I want to know how long it is going to take because I need to be functioning you know for the rest of the week. And when it was informed about the Medical Information Department for the concern, the consumer hung up the call abruptly. Thus, contact details for MI could not be shared and further probing could not be done over the call. Hence, limited information available. The Consumer stated that, I had called earlier but my phone dropped (Further not clarified hence, captured as Initial for report), I was calling because I got the 1st dose yesterday and it's been 24 hours and I have a fever and have a headache and body ache and chills and I wanted to know how long this symptoms is going to last because, I never get sick and I can't afford to get sick and so I do want to know how long this symptoms is going to last, specially because of this 1st dose and if this how the 1st dose feels, I don't know how to get the 2nd dose. The consumer stated that, So what I have to do in the meantime, do I just stay here and get sick and feel sick And again informed about Pfizer Medical Information and also informed the role of Pfizer Drug Safety.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
fatigue; He has elevated cholesterol; Pain at site of jab; This is a spontaneous report received from contactable reporter (Consumer) from a sales representative. The reporter is the patient.  A 54-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 27Mar2021 (Batch/Lot number: unknown) at the age of 54 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 27Mar2021, outcome "unknown", described as "Pain at site of jab"; FATIGUE (non-serious), outcome "unknown", described as "fatigue"; BLOOD CHOLESTEROL INCREASED (non-serious), outcome "unknown", described as "He has elevated cholesterol". Relevant laboratory tests and procedures are available in the appropriate section. Additional Information: The patient had his first COVID Vaccine this morning 27Mar2021 and experienced pain at sight of jab and fatigue. The patient was reported to be 230 (units not provided) and 5 ft. 10 in. The patient was not taking any prescription medicines but was taking multivitamins. He has elevated cholesterol.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.